Medicine News and Research

RSS

Scientists develop new therapeutic approach for treatment of type 2 diabetes

Scientists from the Helmholtz Zentrum Muenchen and the Technische Universitaet Muenchen, together with scientists in the USA, have developed a new therapeutic approach for treatment of Type 2 diabetes. A novel single molecule hormone, which acts equally on the receptors of the insulin-stimulating hormones GLP-1 and GIP, was observed to reduce weight and improve blood sugar.

31 Oct 2013

Black women with vitamin D deficiency during pregnancy more likely to deliver preterm babies

African-American and Puerto Rican women who have low levels of vitamin D during pregnancy are more likely to go into labor early and give birth to preterm babies, research led by the University of Pittsburgh Graduate School of Public Health reveals.

31 Oct 2013

CytoDyn submits protocol to FDA for Phase IIb clinical trial of PRO 140

CytoDyn Inc. ("CytoDyn") (OTCQB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, today announced that CytoDyn Chief Medical Officer David Feigal, M.D., has submitted a revised protocol to the U.S. Food and Drug Administration relating to an upcoming Phase IIb clinical trial of PRO 140, CytoDyn's leading product under development as a treatment for Human Immunodeficiency Virus (HIV) infection.

31 Oct 2013

UofL researcher enters into license and research collaboration agreement with Novartis

The University of Louisville today announced that researcher Dr. Suzanne Ildstad, representing Regenerex LLC, has entered into a license and research collaboration agreement with Novartis to provide access to stem cell technology that has the potential to help transplant patients avoid taking anti-rejection medicine for life and could serve as a platform for treatment of other diseases.

31 Oct 2013

Farmyard proximity benefit to respiratory health

Data from the Netherlands indicate that living in close proximity to livestock farms is associated with decreased respiratory morbidity, including asthma, allergic rhinitis, and chronic obstructive pulmonary disease.

30 Oct 2013

Mediterranean diet exerts greater cardioprotective effect than low-fat diet, shows study

The Nutrition and Obesity Research Group of the UPV/EHU-University of the Basque Country is studying the effects of diet composition on people's body weight and health. Its participation in the PREDIMED project features among the many pieces of research it has conducted.

30 Oct 2013

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

A multidisciplinary team of experts in heart failure, cardiac arrhythmia, and neurosurgery at The Mount Sinai Hospital are now testing nerve stimulation in the neck as a novel therapy for heart failure patients to potentially help relieve their debilitating symptoms of fatigue, shortness of breath, and heart arrhythmias, while reducing their hospitalizations.

30 Oct 2013

USGBC-NCC officially launches Building Health Initiative at Super Heroes Awards Gala

Adobe, CalPERS, Genentech, Google, Kaiser Permanente, salesforce.com, University of California, San Francisco and 20 other corporations and institutions are committed as founding partners in a fast-growing movement to elevate green building as a public health benefit and accelerate the development of transparency standards in building materials.

30 Oct 2013

Once-daily prescription medicine for COPD now available throughout the U.S.

GlaxoSmithKline plc and Theravance, Inc. today announced that BREO ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease, is now available to pharmacies throughout the U.S.

30 Oct 2013

ACA insurance coverage expansions could lead to increased emergency department reimbursements

Researchers at the George Washington University School of Medicine and Health Sciences (SMHS) found that outpatient emergency department encounters could reimburse considerably more after implementation of the insurance coverage expansions of the Affordable Care Act (ACA).

30 Oct 2013

Some safety questions remain unanswered in expedited FDA drug approvals

Fewer patients were studied as part of expedited reviews of new drugs approved by the U.S. Food and Drug Administration (FDA) in 2008 and some safety questions remain unanswered, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

30 Oct 2013

CME Medical helps healthcare professionals to gain confidence in end of life and palliative care

CME Medical, is helping healthcare professionals to gain confidence in caring for patients at the end of their lives. Managing end of life care is a challenge for all health staff, as it often involves dealing with complex and emotional communication with patients and relatives and managing patient symptoms. But now highly sophisticated mannequins – which can talk and simulate signs and symptoms of advanced illness – are being used in a pioneering and unique training programme in Birmingham.

30 Oct 2013

Early detection of heart disease opens up important possibilities of preventing late disease

Heart disease remains the number one cause of early disability and death in the western world and now, surprisingly, has also become the most frequent cause of early death in the developing world.

30 Oct 2013

MiMedx Group reports record revenue in third quarter 2013

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.

30 Oct 2013

Genetic factors may be the same for specific language impairment and language-impaired autism

In the first molecular genetic study of families with a history of both language impairment and autism, scientists may have uncovered a shared origin for the two conditions, an important step toward explaining why some cases of autism are accompanied by language difficulties and others are not. The study, a collaboration of The Research Institute at Nationwide Children's Hospital with experts at Rutgers University, indicates that a disorder called specific language impairment—one of the most common developmental delays in children—may be caused by the same genetic variants that lead to language difficulties in some children with autism.

30 Oct 2013

Wrist artery for coronary angioplasty may benefit women at high risk of blood loss

For women who are at high risk of blood loss, using an artery in the wrist may be better than the groin for routing a stent to the heart during coronary angioplasty, according to researchers at Duke Medicine.

30 Oct 2013

NIH selects two leading researchers to chair panels at geroscience symposium

The National Institutes of Health (NIH) has chosen two leading aging researchers at Albert Einstein College of Medicine of Yeshiva University to chair panels at the first symposium on "geroscience"-the study of how aging influences the onset of chronic diseases.

30 Oct 2013

ATS and ACCP release five recommendations for tests, procedures in pulmonary medicine

A list released today identified five commonly performed tests and procedures in pulmonary medicine that may not always be necessary. The list, part of the ABIM Foundation's Choosing Wisely® campaign, was produced by a collaborative task force assembled by the American Thoracic Society (ATS) and the American College of Chest Physicians (ACCP).

30 Oct 2013

Meta-analysis shows that XRCC1 Arg399Gln polymorphism may be a biomarker of glioma susceptibility

DNA damage is an important mechanism of glioma. X-ray cross-complementing group 1 (XRCC1) is a DNA repair gene that participates in the base excision repair pathway. To date, many studies have been performed to investigate the association between the XRCC1 polymorphisms and risk of cancers such as breast cancer, and gastroesophageal cancer, but the number of studies that focused on glioma is relatively small.

30 Oct 2013

Malaria elimination and insecticide resistance: an interview with Professor Hilary Ranson, Liverpool School of Tropical Medicine

The first malaria elimination programme was in the 1950s and 1960s. Malaria was eliminated from many countries in Asia and the Americas, largely by indoor spraying with insecticide. But the campaign had very little impact in Africa and eventually resources were moved away from malaria control.

30 Oct 2013

Medicine News and Research

Scientists develop new therapeutic approach for treatment of type 2 diabetes

Black women with vitamin D deficiency during pregnancy more likely to deliver preterm babies

CytoDyn submits protocol to FDA for Phase IIb clinical trial of PRO 140

UofL researcher enters into license and research collaboration agreement with Novartis

Farmyard proximity benefit to respiratory health

Mediterranean diet exerts greater cardioprotective effect than low-fat diet, shows study

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

USGBC-NCC officially launches Building Health Initiative at Super Heroes Awards Gala

Once-daily prescription medicine for COPD now available throughout the U.S.

ACA insurance coverage expansions could lead to increased emergency department reimbursements

Some safety questions remain unanswered in expedited FDA drug approvals

CME Medical helps healthcare professionals to gain confidence in end of life and palliative care

Early detection of heart disease opens up important possibilities of preventing late disease

MiMedx Group reports record revenue in third quarter 2013

Genetic factors may be the same for specific language impairment and language-impaired autism

Wrist artery for coronary angioplasty may benefit women at high risk of blood loss

NIH selects two leading researchers to chair panels at geroscience symposium

ATS and ACCP release five recommendations for tests, procedures in pulmonary medicine

Meta-analysis shows that XRCC1 Arg399Gln polymorphism may be a biomarker of glioma susceptibility

Malaria elimination and insecticide resistance: an interview with Professor Hilary Ranson, Liverpool School of Tropical Medicine

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News